(Q63806750)
Statements
A Randomised, Placebo-controlled, Double-blind, Cross-over Study in Healthy Men and Women to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intra-anal Doses of NRL001 for Three Doses Using a Cream Formulation Relative to a Matched Placebo Formulation for Reference (English)
0 references
April 2007
0 references
May 2007
0 references
12
0 references
21 year
0 references
50 year
0 references